Ultralife (NASDAQ:ULBI - Get Free Report) released its quarterly earnings results on Friday. The technology company reported $0.13 EPS for the quarter, missing the consensus estimate of $0.15 by ($0.02), RTT News reports. Ultralife had a return on equity of 7.92% and a net margin of 5.44%. The company had revenue of $50.75 million during the quarter, compared to analysts' expectations of $54.50 million. During the same quarter in the prior year, the business posted $0.21 EPS.
Ultralife Trading Down 0.4%
Shares of NASDAQ:ULBI traded down $0.02 during trading hours on Wednesday, hitting $5.50. 36,343 shares of the company's stock traded hands, compared to its average volume of 70,408. The firm has a market capitalization of $91.48 million, a P/E ratio of 10.00 and a beta of 0.77. The business has a fifty day moving average price of $4.93 and a 200-day moving average price of $6.65. Ultralife has a 1 year low of $4.07 and a 1 year high of $12.40. The company has a debt-to-equity ratio of 0.04, a current ratio of 3.30 and a quick ratio of 1.62.
Wall Street Analysts Forecast Growth
Separately, StockNews.com upgraded shares of Ultralife from a "hold" rating to a "buy" rating in a research report on Monday.
Read Our Latest Stock Report on Ultralife
Hedge Funds Weigh In On Ultralife
An institutional investor recently raised its position in Ultralife stock. Bank of America Corp DE lifted its stake in Ultralife Co. (NASDAQ:ULBI - Free Report) by 30.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 12,067 shares of the technology company's stock after purchasing an additional 2,836 shares during the period. Bank of America Corp DE owned about 0.07% of Ultralife worth $90,000 at the end of the most recent quarter. 30.68% of the stock is owned by institutional investors and hedge funds.
About Ultralife
(
Get Free Report)
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.
Recommended Stories
Before you consider Ultralife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ultralife wasn't on the list.
While Ultralife currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
